Exoplanet detectives create catalog of ‘light-fingerprints’

Researchers have created a reference catalog using calibrated spectra and geometric albedos of 19 of the most diverse bodies in our solar system.  

DOE funding will help researchers create new quantum states of matter

A research group led by Andrej Singer, assistant professor of materials science and engineering, has won a grant from the Department of Energy for research aimed at creating new quantum states of matter.

Accelerator project gets push from National Academy of Sciences

A National Academy of Sciences committee has endorsed the idea of building an electron-ion collider in the U.S. The project would be helped by research done at CBETA, Cornell's energy recovery linear accelerator.

A kernel of promise in popcorn-powered robots

New research from Cornell's Collective Embodied Intelligence Lab examines how popcorn’s unique qualities can power inexpensive robotic devices that grip, expand or change rigidity.

Guinness World Record for micro view into hidden worlds

Guinness World Records has officially recognized a Cornell collaboration’s achievement: an electron microscope resolution of 0.39 ångströms.

Essentials

Awards promote life sciences research and industry partnerships in NY

Nine projects were awarded Center for Advanced Technology grants in 2018-2019. The grants are given to faculty members in life sciences fields who partner with a New York state industry for research and development.

Apps make it easy for domestic abusers to spy

A new study from Cornell researchers finds domestic abusers can choose from thousands of apps to spy on their partners, from traditional spyware to software intended for legitimate purposes, like finding phones.

Why do we slack on saving? Blame the brain

Humans have a cognitive bias toward earning, which makes us unconsciously spend more brain power on earning than on saving, according to a new Cornell study.

Study reveals how promising cancer drug works for best use

A study describes for the first time how a promising FDA-approved cancer drug – currently in clinical trials – works to effectively kill cancer cells.